A randomized, controlled, blinded human trial of GHK-Cu monotherapy, with a vehicle-only control (and a needling-plus-vehicle arm if a procedure is used), objective endpoints such as blinded global photography and target-area hair counts over at least several months, adequate statistical power, pre-registration, and independent replication
If you want to understand: why recovery sometimes stalls why peptides underperform for some people and how to avoid wasting time and money Start with the Injury, Joint & Recovery Blueprint
This is crucial for all people, whether active or not
Immunocal Sport Glutathione Supplement Train Like a Professional
GLOW Dosing Protocol The standard protocol for GLOW is 2.8 mg per injection: 2 mg GHK-Cu with 400 mcg each of BPC-157 and TB-4
Upon intravenous injection, the nanoreactors can systemically activate the immune system, and nearly fully eradicate an aggressive osteosarcoma tumor inside a mouse model